Taurochenodeoxycholic Acid

CAS No. 516-35-8

Taurochenodeoxycholic Acid( 12-Deoxycholyltaurine )

Catalog No. M18702 CAS No. 516-35-8

Taurochenodeoxycholic acid is one of the main bioactive substances of animals' bile acid.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 35 In Stock
50MG 53 In Stock
100MG 80 In Stock
200MG 115 In Stock
500MG 197 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Taurochenodeoxycholic Acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Taurochenodeoxycholic acid is one of the main bioactive substances of animals' bile acid.
  • Description
    Taurochenodeoxycholic acid is one of the main bioactive substances of animals' bile acid.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    12-Deoxycholyltaurine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Caspase| TNF-α
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    516-35-8
  • Formula Weight
    499.7
  • Molecular Formula
    C26H45NO6S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 25 mg/mL; 50.03 mM
  • SMILES
    O=S(=O)(O)CCNC(=O)CC[C@@H](C)[C@H]4CC[C@@H]1[C@]4(C)CC[C@@H]2[C@@]3(C)CC[C@@H](O)C[C@H]3C[C@@H](O)[C@@H]12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wang X, et al. Taurochenodeoxycholic acid induces NR8383 cells apoptosis via PKC/JNK-dependent pathway. Eur J Pharmacol. 2016 Sep 5;786:109-15.
molnova catalog
related products
  • Beta-MSH (1-22) huma...

    β-Melanocyte Stimulating Hormone (MSH), human (Synonyms: Beta-MSH (1-22) (human)) β-Melanocyte Stimulating Hormone (MSH), human, a 22-residue peptide, acts as an endogenous melanocortin-4 receptor (MC4-R) agonist.

  • AMPPD

    AMPPD is a 1,2-dioxo-cyclohexane derivative and a substrate for hypersensitive alkaline phosphatase.

  • Batyl alcohol

    Batyl alcohol has been approved in clinical treatment of aleucocytosis that caused by radiotherapy, chemotherapy.